Search: Faculty | Fellows | Staff | Research Assistants | Former Faculty and Fellows
Kenneth Freedberg, MD, MSc
Dr. Freedberg is a Professor of Medicine at Harvard Medical School, Professor in the Department of Health Policy and Management at the Harvard T.H. Chan School of Public Health, and a physician at Massachusetts General Hospital.
He is the Director of MPEC, Director of the Program in Clinical Epidemiology and Outcomes Research at the Harvard University Center for AIDS Research, and Director of the Program in HIV Research in the Division of General Internal Medicine at Massachusetts General Hospital. His research interests focus on HIV and tuberculosis, as well as other chronic disease clinical outcomes and health policy, utilizing the methods of comparative effectiveness, cost-effectiveness analysis, clinical epidemiology, and implementation science.
Dr. Freedberg earned an MD from Harvard Medical School and also holds an MSc from the Harvard T.H. Chan School of Public Health.
Ingrid Bassett, MD, MPH
Dr. Bassett is an Associate Professor of Medicine at Harvard Medical School, and an infectious disease physician at Massachusetts General Hospital.
She is the Co-Director of MPEC and Director of the Developmental and Mentoring Core at the Harvard University Center for AIDS Research. Her research interests include evaluating strategies for improving uptake and retention in HIV and TB services in South Africa.
Dr. Bassett earned an MD from Harvard Medical School and an MPH from the Harvard T.H. Chan School of Public Health.
Lisa Bebell, MD
Dr. Bebell is an Instructor at HMS and Assistant in Medicine at MGH in the Infectious Diseases Unit.
As a physician, she practices Critical Care Medicine and Infectious Diseases, though she spends most of her time carrying out research on peripartum infections. Her current research focus is better understanding the role of the placenta in transplacental antibody transfer and early life health outcomes, particularly among HIV-exposed, uninfected children. Lisa also investigates antimicrobial resistance in resource-limited settings and bedside ultrasound use in patient management.
She received her MD from Columbia University College of Physicians and Surgeons and completed her residency at the University of California, San Francisco.
Andrea Ciaranello, MD, MPH
Dr. Ciaranello is an Associate Professor of Medicine at Harvard Medical School and an infectious disease physician at Massachusetts General Hospital. She serves as director of the Perinatal Infectious Disease Program at MGH and Director of the Program in Health Economics and Modeling at the Harvard University Center for AIDS Research.
She is also Co-Chair of the US Department of Health and Human Services Panel on Treatment of Pregnant Women with HIV Infection and Prevention of Perinatal Transmission, and has served as technical consultant for UNAIDS and WHO about simulation modeling and cost-effectiveness related to pediatric HIV and mother-to-child HIV transmission.
Her research interests involve the use of simulation models to examine the long-term clinical outcomes and cost-effectiveness of strategies to care for women, children, and adolescents living with and at risk for HIV. Dr. Ciaranello also uses modeling methods to evaluate strategies to prevent and manage COVID-19 and is working with public K-12 schools to guide safe in-person learning during the COVID-19 pandemic.
Dr. Ciaranello earned an MD from the Yale School of Medicine and an MPH from the Harvard T.H. Chan School of Public Health.
Caitlin Dugdale, MD
Dr. Dugdale is an adult infectious disease physician at Massachusetts General Hospital, Instructor at Harvard Medical School, and MPEC research faculty.
Her research focuses on the cost-effectiveness of interventions to promote maternal and child health and reduce vertical transmission of HIV in resource-limited settings.
She earned her MD from the Indiana University School of Medicine.
Esther Freeman, MD, PhD
Dr. Freeman is an Associate Professor at Harvard Medical School and a board certified dermatologist and epidemiologist, specializing in global health dermatology. She has worked to improve healthcare, especially those affected by HIV, in sub-Saharan Africa, Latin America, and southeast Asia since 2003.
She has collaborated with the World Health Organization since 2011, to establish guidelines for the treatment of HIV-associated skin conditions in the developing world. She has won the American Academy of Dermatology’s Member Making a Difference Award, as well as the most highly cited author in the area of epidemiology in AIDS in 2009.
Her current work centers around Kaposi’s sarcoma, a potentially deadly tumor associated with HIV that first appears on the skin. Her work has been supported by the National Institutes of Health (NIH), the Dermatology Foundation, the American Skin Association, the Harvard Center for AIDS Research, and the Medical Dermatology Society.
She earned her PhD in Epidemiology from the London School of Hygiene and Tropical Medicine and her MD from Harvard Medical School.
Emily Hyle, MD, MSc
Dr. Hyle is an infectious disease physician at Massachusetts General Hospital and Assistant Professor in Medicine at Harvard Medical School.
Her research interests include using cost-effectiveness analysis to investigate policy-relevant questions for the clinical care of people with HIV, including point-of-care technologies, virologic resistance, and non-communicable diseases among people with HIV, in the US and resource-limited settings. Dr. Hyle also collaborates with the Global TravEpiNet Consortium to investigate the cost-effectiveness of pre-travel medicine.
Dr. Hyle earned her MD from the Perelman School of Medicine at the University of Pennsylvania, as well as a DTMH from the Gorgas Institute in Lima, Peru and an MSc in Epidemiology for the Harvard T.H. Chan School of Public Health.
Jennifer Manne-Goehler, MD, DSc
Dr. Manne-Goehler is an adult infectious diseases physician at Massachusetts General Hospital and the Brigham and Women’s Hospital.
Dr. Manne-Goehler’s research interests lie at the intersection of HIV and metabolic disease. She serves as a co-investigator on the Health and Aging in Africa: A Longitudinal Study of an INDEPTH Community in South Africa (HAALSI) cohort study an d is a co-founder of the Global Health + Population Project on Access to Care for Cardiometabolic diseases (HPACC). Her current projects include NIH-funded research on the prevention of metabolic disease in people with HIV and use of artificial intelligence methods to improve evaluation of diabetes risk in this population. She has also served as an advisor to the World Health Organization regarding their global diabetes strategy. She maintains secondary research interests in Chagas disease and gender equity in academic medicine.
She completed her MD at Boston University School of Medicine and a doctorate at the Harvard T. H. Chan School of Public Health.
Suzanne McCluskey, MD
Dr. McCluskey is an Instructor at Harvard Medical School and an Assistant in Medicine in the MGH Division of Infectious Diseases, where she serves on the Infectious Diseases consult service.
Her research focuses on the epidemiology and management of HIV treatment failure and antiretroviral drug resistance in resource-limited settings with projects based in southwestern Uganda and KwaZulu Natal, South Africa. Her current work aims to explore novel strategies to more accurately differentiate between patients failing therapy with resistant versus wild-type virus and to evaluate the impact of HIV drug resistance and adherence patterns on the effectiveness of dolutegravir-based ART regimens in sub-Saharan Africa.
She received her MD from the University of Alabama at Birmingham School of Medicine
Anne Neilan, MD, MPH
Dr. Neilan is a medicine and pediatrics-trained adult infectious disease physician at Massachusetts General Hospital and an Instructor at Harvard Medical School. Her research interests include the use of simulation modeling and cost-effectiveness analysis to inform care strategies for adolescents with HIV and at risk of HIV.
She is also the Director of the Modeling Core for the national Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN 161).
She earned her MD and MPH from The Mount Sinai School of Medicine in New York. She was a Fulbright Scholar in Italy and a Fogarty Scholar in Peru.
Crystal North, MD, MPH
Dr. North is a pulmonologist and critical care physician at Massachusetts General Hospital, an Instructor in Medicine at Harvard Medical School, an Associate in Global Health at MGH Center for Global Health, and a visiting scientist at Harvard T.H. Chan School of Public Health.
Her research focuses on understanding the epidemiology of chronic lung disease in resource-limited settings. In particular, she is investigating the influences of air pollution and chronic HIV infection on lung inflammation and impaired lung function in Uganda.
Dr. North earned her MD from the University of Washington and her MPH from the Harvard T.H. Chan School of Public Health. She completed internal medicine residency at New York Presbyterian Hospital-Cornell, pulmonary and critical care fellowship at the Harvard combined program, and she was a Fogarty fellow in Uganda and a Wyss MGH Global Health Fellow.
Krishna Reddy, MD, MS
Dr. Reddy is a pulmonologist and critical care physician at Massachusetts General Hospital and an Assistant Professor of Medicine at Harvard Medical School.
His research program focuses on informing clinical and public health policy for tuberculosis, HIV-related comorbidities, and tobacco and nicotine in the US and internationally. He applies methods of simulation modeling, clinical epidemiology, and cost-effectiveness analysis to study policy-relevant clinical and economic outcomes.
Dr. Reddy earned an MD from Harvard Medical School and an MS from the Harvard T.H. Chan School of Public Health. He was a Fulbright Scholar in Spain and a Fogarty Scholar in Peru.
Fatma Shebl, MD, PhD
Dr. Shebl is the Director of Biometry for MPEC and a Member of the Faculty at Harvard Medical School. After receiving her PhD in 2008 , she was a research fellow at the National Institutes of Health and then joined the faculty at the Yale School of Public Health where she taught advanced analytic methods, biostatistics, and epidemiology courses.
Dr. Shebl’s research interests are in the areas of infectious disease epidemiology and its intersection with chronic diseases and cancers. Dr. Shebl is also interested in maternal and child health and community trials. She specializes in applying advanced analytic methods and analysis of large datasets.
Dr. Shebl earned her MD at the University of Alexandria in Egypt and her PhD from the University of Maryland in Baltimore.
Mark Siedner, MD, MPH
Dr. Siedner is an Associate Professor of Medicine at HMS, an Assistant Physician in the Division of Infectious Diseases at MGH, and the Head of Clinical Research at the Africa Health Research Institute in KwaZulu-Natal, South Africa.
His research program is focused on improving health and quality of life for people living with HIV in sub-Saharan Africa, and includes interventional trials, implementation research, and observational clinical epidemiology methods. He mentors junior and aspiring investigators on both sides of the Atlantic.
He received his MD and MPH from Johns Hopkins University.
Jessica Becker, MD
Dr. Becker is a Child and Adolescent Psychiatrist at Massachusetts General Hospital, an Instructor at Harvard Medical School, and a member of the Harvard-wide Pediatric Health Services Research Fellowship. She completed her combined adult and child/adolescent psychiatry training at Massachusetts General Hospital and McLean Hospital in 2020.
Her research focuses on the interface of medical and psychiatric disease in children and adults. She is working on several ongoing modeling analyses at this intersection with Dr. Freedberg and Dr. Reddy, and is working to develop a novel simulation model of pediatric mental illness under the guidance of Dr. Freedberg and Dr. Ciaranello.
Prior to her clinical training, she completed her MD at Yale School of Medicine and her AB in Economics at Harvard College. She is currently completing her Master of Public Health degree at the Harvard T.H. Chan School of Public Health.
John Chiosi, MD
Dr. Chiosi is an Infectious Disease fellow at Massachusetts General Hospital.
He is interested in the infectious complications of substance use disorder, including injection drug use. He is working with Dr. Ciaranello to develop a simulation model of infectious morbidity and mortality among people with opioid use disorder in order to project the clinical and economic impact of the opioid use epidemic in the US.
He earned his MD from the Icahn School of Medicine at Mount Sinai and completed his residency and chief residency in Internal Medicine-Pediatrics at Tulane University.
Akash Gupta, MD
Dr. Gupta is an adult Infectious Disease fellow at MGH, and previously completed his combined Medicine/Pediatrics residency at MGH.
He is interested in the intersection of infectious disease, global health, and substance use. He is working with his mentor Dr. Bassett to evaluate the impact of substance use on retention in care among patients in tuberculosis and HIV treatment programs in Cape Town, South Africa.
Prior to residency, he received his MD at Yale School of Medicine, and his BA in History and Environmental Biology from Columbia University.
Jana Jarolimova, MD, MPH
Dr. Jarolimova is a research fellow at MPEC and a physician in Infectious Diseases at MGH. She previously completed her internal medicine training in the MGH Global Medicine residency program.
She is interested in care delivery for sexually transmitted infections and HIV in resource-limited settings. Her previous work focused on rural primary care delivery, HIV, and disparities in reproductive health, primarily in western Uganda. She is working with Dr. Bassett to study implementation of STI care and HIV prevention in South Africa.
She received her medical degree from Harvard Medical School and MPH in Clinical Effectiveness from the Harvard School of Public Health.
Menan Gérard Kouame, MD, MPH
Dr. Kouame is a visiting researcher from Côte d’Ivoire.
He is currently a PhD student in epidemiology at the University of Bordeaux. He will be working on a modeling project assessing the impact of different strategies for care of people with HIV and HBV in Côte d’Ivoire.
He received a Doctor of Medicine Degree from the Faculty of Medicine of Abidjan in Côte d’Ivoire and a Master’s degree in Research in Public Health from ISPED, University of Bordeaux.
Amir Mohareb, MD
Dr. Mohareb is an Instructor at Harvard Medical School and an infectious diseases physician at Massachusetts General Hospital. His research focuses on HIV and Hepatitis B management in resource-limited settings. He also has clinical and research interests in forcibly displaced populations.
He earned his MD from Johns Hopkins University School of Medicine.
Laura Platt, MD
Dr. Platt is a fellow in Infectious Diseases at MGH and Brigham and Women’s hospital.
Based upon an underlying interest in reducing health care disparities and expanding access to care for vulnerable adults, her prior research endeavors have ranged from interventions to improve primary care experiences for adults with developmental disabilities to evaluating recidivism among patients transplanted for acute alcoholic hepatitis. She will conduct implementation research with Dr. Bassett focusing on community-based interventions for expanding access to sexual health services such as STI screening, treatment and PrEP.
She completed her MD at Duke University and residency in internal medicine at Johns Hopkins Hospital.
Yuvaram Reddy, MD
Dr. Reddy is a nephrology fellow at Brigham and Women’s Hospital and Massachusetts General Hospital.
His research interests are focused on understanding barriers that lead to the slow uptake of peritoneal dialysis and home dialysis modalities. He hopes to achieve this through understanding, improving and affecting health care policy with the use of simulation modeling and cost-effectiveness analyses. He will be working closely with Dr. Rochelle Walensky and Dr. Reddy.
He earned his MD from Sri Ramachandra University in India and completed his residency in internal medicine at Boston Medical Center.
Alyssa Amick, MPH – Research Specialist
Alyssa joined MPEC in August 2020. She currently works with Dr. Dugdale on cost-effectiveness analyses of interventions currently undergoing clinical trials in Mozambique and Malawi to prevent and reduce vertical transmission of HIV. She is also working with Dr. Ciaranello on improving EID rates in sub-Saharan Africa. In addition to these projects, Alyssa helps manage the Center’s Twitter account.
Alyssa graduated in 2020 with an MPH in the epidemiology of microbial diseases with a concentration in public health modeling from the Yale School of Public Health. She also received a BS in Molecular, Cellular and Developmental Biology from Yale in 2019.
Dara Baltin – Recruiting and Training Coordinator
Dara joined MPEC in January 2020. She works closely with MPEC’s Operations Manager and the research and operations teams to recruit candidates for all posted positions at MPEC. Dara works across teams to improve recruiting processes in place for each position, and is currently working with the Center’s internal Diversity, Equity, and Inclusion group to provide better outreach to universities and research centers around the country.
Dara graduated from Hofstra University with a BA in Psychology and made a recent career change from the field of human services. She is currently a part-time MBA candidate at Suffolk University.
Shana Carvalho – Operations Coordinator
Shana joined the MPEC team in May 2019.
She has a background and experience in global curriculum development and early childhood education.
She earned a BS in Public Health from the University of Massachusetts Lowell.
Vijeta Deshpande, MS – Research Specialist
Vijeta joined MPEC in May 2019. He works with Drs. Freedberg, Kazemian, Shebl and Pei on different projects leveraging CEPAC for analyzing cost-effectiveness of PrEP for various populations under consideration.
Vijeta graduated from the University of Massachusetts Amherst in May 2019 with a Masters degree in Operations Research. In his thesis he developed a mathematical model which enabled cost-effectiveness analysis of mammography screening for middle income population settings.
Clare Flanagan, MPH – Research Program/Project Manager
Clare Flanagan joined MPEC in June 2019. Before joining MPEC she worked on the endTB study with Partners In Health. She has a background in the implementation and management of research projects.
Clare holds an MPH in Global Health & Population from the Harvard T.H. Chan School of Public Health and a BA in Government and Women’s & Gender Studies from Georgetown University.
Rebecca Gilbert – Project Coordinator
Rebecca joined MPEC in July 2019 after working as a project coordinator at the MGH Center for Global Health. Previously, she was a research assistant at the Harvard Pilgrim Health Care Institute. She currently works with Dr. Siedner on projects related to improving health for people living with HIV and non-communicable diseases in Uganda and South Africa.
She received her BA in Anthropology with a focus in global health from Washington University in St. Louis.
Nicole Holt, MPH – Compliance Manager
Nicole joined MPEC in 2014 after previously working as a Project Coordinator and Lab Manager at Spaulding Rehabilitation Hospital. She has a background in the coordination and implementation of research studies. She holds a BA in Psychology and History from Brown University and earned a MPH from Oregon State University with a focus in Health Promotion.
In her role as Compliance Manager for MPEC, Nicole works with investigators to ensure compliance with NIH and institutional policy regarding protection of human subjects in research, data protection and management, conflict of interest reporting, and public access publication requirements. She also assists with the preparation of grant submissions and progress reports.
Through close collaboration with MPEC faculty, fellows, and staff, Nicole ensures research projects are compliant through the lifecycle. She especially enjoys working with junior investigators and conducting compliance trainings and consultations with new fellows and staff.
Jodi Kurtz, MSM, MA – Administrative Manager
Jodi joined MPEC in 2012 and has a wide array of experience with sponsored research administration and operations management. She has a BS from Carnegie Mellon University, an MA from the University of Washington, and an MScM with a specialization in Research Administration from Emmanuel College.
In her role as Administrative Manager for MPEC, Jodi is responsible for setting direction and coordinating the operational and financial aspects of the center. She collaborates closely with Center leadership to continually assess and direct management of personnel, finances, research, and strategic planning.
After attaining the designation of Certified Research Administrator in 2014, Jodi has been committed to supporting research administration training and education across the MGH community. She is a founding member of the Partners 2.0 Training Steering Committee, presents at the Harvard CFAR K workshop, hosts annual training sessions for new investigators, and teaches research administration fundamentals to new staff members.
Allison McCann – Grant and Finance Coordinator
Allison joined MPEC in July 2020 after graduating from Dartmouth College with a BA in Political Science and Government, and a concentration in Comparative Politics.
Allison works alongside the Grant and Finance Manager and Compliance Manager to manage MPEC’s implementation and modeling grant portfolio. She assists in the sponsored research grant application process, guides and educates early investigators through pre- and post-award grant processes, and helps to monitor study records, human subjects work, and data transfers. Allison is also the primary person for procurement needs and monitors and executes fiscal functions of the Center.
Jaime Nangle – Operations Manager
Jaime joined MPEC in 2013 after working for two and a half years at Mass General Brigham serving as a procurement and accounts payable resource for the research community. She holds a BA in Psychology from Wheaton College in Massachusetts.
In her role as the Operations Manager for the MPEC, Jaime develops, implements, and oversees Center-wide policies and procedures improving administrative, fiscal, and operations management. She collaborates with MPEC faculty and leadership to develop job descriptions which accurately and thoroughly address MPEC hiring needs in compliance with MGH HR standards and works closely with the Recruitment and Training Coordinator throughout all phases of RA recruiting. Jaime also coordinates required passport and visa documents, maintains familiarity with materials management policies and procedures, and continues to serve as resource for procurement and expense questions.
Jaime serves as the Chairperson for the MPEC Events Committee and is dedicated to coordinating vital team-building events throughout the year. Jaime is also a member of several steering committees and working groups devoted to fostering an even greater sense of community within MPEC, as well as the Mongan Institute, and has been invited to participate in MGH and MGB training, onboarding, and professional development pilot programs.
Christopher Panella – Programmer Analyst
Christopher joined MPEC in 2019. As programmer for the group, he develops software projects including continued improvements and extensions to the CEPAC model.
He graduated from the University of Colorado, Boulder in 2018 with a BA in Physics and Mathematics.
Pamela Pei, PhD – Research Scientist
Pamela joined MPEC in 2011. She has a PhD in Operations Research from Massachusetts Institute of Technology, a MS/BS in Applied Mathematics, and BA in Economics from Johns Hopkins University.
She is currently working with Dr. Reddy on assessing the value of a new TB diagnostic test, and with Dr. Hyle on an elimination of the HIV epidemic project.
In her role, Pamela lends her operations research skills to help develop various in-house modeling tools for the team. She is responsible for developing value of information tools, which comprises a feature that allows for probabilistic sensitivity analysis; a multi-cohorts tool to help expedite the processing of analyses that require multiple cohorts to be considered simultaneously; and a Markov-based module that tracks the epidemiology of HIV over time.
Lizzie Qian, MPH – Data Analyst
Lizzie joined MPEC in August 2019. She assists the group with statistical data analysis projects and generating data inputs for the CEPAC model.
She holds an MPH in Epidemiology and Biostatistics from Boston University School of Public Health and has a Bachelor of Medicine in Preventive Medicine from Tianjin Medical University in China and completed her rotation at Tianjin Baodi Hospital.
Zahra Reynolds, MPH – Research Program/Project Manager
Zahra joined MPEC in July 2019. She will work closely with Dr. Siedner. She previously worked as a Research Associate at MEASURE Evaluation at the University of North Carolina at Chapel Hill where she designed and managed studies improving the availability of data on male HIV case finding in Namibia and Eswatini, characterizing the male partners of adolescent girls and young women in Swaziland, and understanding the behavioral risks of key populations with HIV in Guyana in order to improve programming for high risk populations.
Zahra has a BA in History of Art from Bryn Mawr College and an MPH in Maternal and Child Health from the University of North Carolina at Chapel Hill.
Justine Scott, MPH – Senior Research Program/Project Manager
With a background in public health and biomedical research, Justine has focused on research program management for MPEC since 2016. She contributes to strategic and operational management across the Center and manages a team of research assistants and other research staff. She oversees a portfolio of CEPAC modeling projects and provides program management across the modeling team. Motivated by the pursuit of global health equity, she is interested in research that addresses health disparities and social determinants of health both domestically and internationally.
Justine holds an MPH in Health Policy and Management from the Harvard T.H. Chan School of Public Health and a BA in Biology and Government from Colby College.
Virginia Talbot – Programmer Analyst
Virginia joined MPEC in June 2020, and helps to build and maintain simulation models. Her strong background in pure as well as applied mathematics adds a unique perspective and high level of flexibility to her programming and data analysis projects. A British-American dual citizen, Virginia also has strong family ties to Southern Africa and to the healthcare field, which lend special meaning to her work with the group.
She began her Bachelor’s Degree in Mathematics at Williams College and later transferred to Lesley University, where she completed it in 2019.
Yao Tong, MS – Data Analyst
Yao joined MPEC in December 2020 after graduating from Yale University with an MS in Biostatistics. She also received a BA in Economics and Communication Studies from the University of Michigan, and an MS in Comparative Media Studies from MIT. She is passionate about leveraging data analytics to facilitate global health research, which led to her decision to join MPEC.
At MPEC, she works with the biometry unit to provide statistical support to research projects. Currently, she works with Drs. Neilan and Shebl on enrollment in a pediatric biorepository during the COVID-19 pandemic. She is also working with Drs. Siedner and Dustin Rabideau to examine HIV treatment adherence, virologic suppression, and drug resistance among individuals initiating antiretroviral therapy in Uganda and South Africa. In addition to these projects, Yao helps analyze recruitment data for MPEC’s internal Diversity, Equity, and Inclusion initiatives.
Elizabeth Van Blarcom, JD – Grant and Finance Manager
Leaving her work as an attorney behind, Ellie joined MPEC in 2018 and has a wide array of experience with sponsored research administration and fiscal management. She has a BA from Juniata College and a JD from New England Law ǀ Boston.
In her role as Grant and Finance Manager for MPEC, Ellie provides oversight and management to the Center’s sponsored research portfolio throughout the award life cycle. Working closely with the Center’s Principal Investigators and outside collaborators, she ensures the successful execution of sponsored awards through counseling Investigators on fiscal strategy, monitoring activities and addressing questions of collaborating subaward sites, and conducting monthly assessments of fund activities.
Dani Zionts, MScPH – Research Program/Project Manager
Dani joined MPEC in May 2020 after years working in health care delivery and implementation science research at Stanford University. She has a BA from Brandeis University and an MScPH from McGill university, focusing on epidemiology.
As a Clinical Research Program/Project Manager in the Implementation Program, key responsibilities include growing and supporting the expanding Implementation Program and identifying, training, and supervising the research assistants who start their careers at MPEC. She works closely with Dr. Bassett and other Implementation Program investigators and RAs to advance their research, notably in the fields of community-based HIV and sexual health care in South Africa; domestic sexual health services; and COVID-19.
Chris joined the MPEC in June 2020 after graduating from Yale University with a BS in Economics and in Molecular, Cellular, and Developmental Biology.
Chris is currently working with Dr. Dugdale to determine the clinical and economic impacts of using broadly neutralizing antibodies as a form of passive immunoprophylaxis for infants exposed to HIV. He is also working with Drs. Siedner and Freedberg to assess how additional U.S. investment in COVAX, a global initiative to ensure equitable COVID-19 vaccine access, would impact health outcomes internationally. In addition to research, Chris enjoys working on internal Diversity, Equity, and Inclusion initiatives and growing the Center’s social media presence.
Audrey joined MPEC in July 2018. She is currently working with Dr. Hyle on projects related to measles vaccination in pre-travel clinics and genotype testing for HIV drug resistance in South Africa. She is also working with Dr. Neilan on a modeling project related to adherence interventions for adolescents and young adults living with HIV in the United States.
She graduated from Middlebury College in 2018 with a BA in Biochemistry and minors in Global Health and Art History.
Ravi joined MPEC in August 2020 after graduating from the University of Pennsylvania with a BA in Biological Physics and a minor in Religious Studies.
Ravi currently works with Dr. Ciaranello on evaluating strategies for the rollout of pediatric Dolutegravir in South Africa. He also works with Dr. Neilan to assess the impact of COVID-related HIV care interruptions for adolescents and young adults in the US.
Grace joined MPEC in August 2020 after graduating from Williams College with a BA in Sociology and Public Health. Prior to joining the team, she lived in rural Alabama as a Project Horseshoe Farm Community Health Fellow, working to improve the outcomes of underserved individuals by focusing on social determinants of health.
Grace is currently working with Drs. Bassett and Freeman on their COVID-19 data registries, which will be used to answer questions about long-term outcomes of the virus, both for MGH patients and for global dermatological patients. She is also working on the MGH DISCOVER COVID-19 study, which is examining whether the Pfizer and Moderna vaccines prevent asymptomatic infection.
Delaney joined MPEC in July 2019. He currently works with Dr. Reddy on evaluating the cost-effectiveness of smoking cessation interventions for people living with HIV (PLWH) and Drs. Kazemian and Freedberg on evaluating the cost-effectiveness of a psychosocial intervention for men who have sex with men (MSM) in India.
He graduated from Cornell University in 2019 with a BS in Human Biology, Health, and Society and minors in Biomedical Sciences, Infectious Disease Biology, and Policy Analysis and Management.
Ege joined MPEC in September 2019 after graduating from Harvard College with a BA in Human Developmental & Regenerative Biology.
She is currently working with Dr. Neilan on evaluating the clinical outcomes and cost-effectiveness of Pre-Exposure Prophylaxis (PrEP) in high risk young men who have sex with men. She is also working with Dr. Ciaranello on modeling the clinical outcomes and cost-effectiveness of remdesivir treatment for COVID-19.
Mary joined MPEC in June 2020. She currently works with Dr. Hyle on modeling the costs and health impacts of non-communicable diseases in people with HIV and with Drs. Freedberg and Stephen Resch on evaluating the cost-effectiveness of a combination prevention initiative intended to increase ART coverage and decrease HIV transmission in Botswana.
She graduated from Wellesley College in 2020 with a BA in Economics.
Kieran joined MPEC in June 2020. His research interests lie in using modeling, simulation, and optimization to tackle problems at the intersection of biology, systems science, and medicine.
He graduated from the University of Pittsburgh in 2020 with a BS in Chemical Engineering.
Adi joined the MPEC in July 2018. He currently works with Dr. Neilan on modeling improved diagnostic testing algorithms for HIV, with Dr. Ciaranello on evaluating the cost-effectiveness of maternal HIV screening during infant immunization visits, and with Dr. Hyle on analyzing trends of antibiotic prescriptions for self-treatment of Travelers’ Diarrhea.
He graduated from Wesleyan University in 2018 with a BA in Chemistry, Molecular Biology and Biochemistry, and Science in Society.
Linh joined MPEC in July 2019 after graduating from Amherst College with a BA in Mathematics and in French Language and Literature.
She currently works with Dr. Neilan to model the cost-effectiveness of long-acting injectable HIV PrEP among men who have sex with men, and with Drs. Pei and Reddy to evaluate the value of hypothetical clinical trials of new tuberculosis diagnostic tests in resource-limited settings.
Previously, Linh worked with Dr. Freedberg to examine the clinical and economic outcomes of different management strategies for individuals experiencing sheltered homelessness during the COVID-19 pandemic, and with Dr. Bebell to explore the relationship between chronic placental inflammation in pregnant women with HIV and the heath outcomes of their children.
Stephanie joined MPEC in August 2020 after graduating from Florida State University with a BS in International Affairs and a minor in Urban and Regional Planning.
Stephanie currently works with Dr. Reddy on the Simulation of Tobacco and Nicotine Outcomes Policy (STOP) model to analyze tobacco use behaviors and outcomes. Her projects include: addressing tobacco use and cessation among vulnerable populations in the US population to increase health-adjusted life expectancy, developing and administering a survey on tobacco-related behaviors with collaborators in South Africa, and reviewing smoking interventions for people living with HIV. In conjunction with research, Stephanie works with Dr. Ciaranello and others to update the COVID-19 School and Community Resource Library. She also participates in the Diversity, Equity, and Inclusion working group.
Nicole joined MPEC in August, 2018 after graduating from Wesleyan University with a BA in Biology and Science in Society. She works with Dr. Ciaranello to model the cost-effectiveness of various prevention of vertical transmission and early infant diagnosis interventions in resource-limited settings and with Dr. Freeman to evaluate the cost-effectiveness of chemotherapy regimens for Kaposi’s Sarcoma in people with HIV in Kenya.
She previously worked with Dr. Reddy to model the cost-effectiveness of a urine-based diagnostic tool for tuberculosis in people with HIV in South Africa and Malawi, and with Dr. Rochelle Walensky on several analyses examining treatment and prevention for HIV and HIV-related costs and policy in the United States.
Giulia joined MPEC in September 2019. She currently works with Dr. Ciaranello on modeling projects related to point-of-care early infant diagnosis (EID) of HIV in Zimbabwe, as well as the introduction of new guidelines and the implementation of new antiretroviral drugs (ARVs) for children living with HIV in Cote d’Ivoire, South Africa, and Zimbabwe. She also works with Dr. Ciaranello and collaborators in Zimbabwe on modeling the prevention of mother to child transmission (PMTCT) of HIV.
She graduated from Middlebury College in 2019 with a BA in Molecular Biology and Biochemistry and a minor in Psychology.
Nicholas Rahim joined MPEC in August 2020. He currently works with Dr. North on the DISCOVER COVID-19 project, investigating whether current vaccines for COVID-19 prevent asymptomatic infection. He is also working with Dr. Bebell on two studies: one that reports on the possible impact of COVID-19 on pregnancy and another that investigates the role of the placenta on antibody and early-life outcomes for HIV-exposed children. Additionally, he is working with Dr. Manne-Goehler to study the delivery of diabetes preventive care in low- and middle- income countries.
Nicholas graduated from Cornell University in May 2020 with a BA in Economics and History and a minor in Africana Studies.
Eli joined MPEC in July 2019. He currently works with Dr. Reddy on modeling tobacco and electronic nicotine delivery systems and with Dr. Hyle on modeling noncommunicable diseases in an aging population of people living with HIV.
He graduated from Vassar College in 2019 with a BA in Mathematics and Statistics and a correlate sequence in Jewish Studies.
Tijana joined MPEC in August 2018. She has worked with Dr. Hyle on non-communicable disease in people with HIV in the United States, and on an evaluation of pre-travel interventions. She is also working with Dr. Ciaranello on forecasting the clinical and economic benefits of provider-initiated HIV screening and testing in pediatric care.
Tijana graduated from Yale University in 2018 with a BS in Economics and in Molecular, Cellular, and Developmental Biology. She is currently pursuing MS studies in International Health Policy/Health Economics at LSE in London, with a particular interest in health system financing, health technology assessment, and equitable access to medicines.
Ashley joined MPEC in June 2020. She currently works with Dr. Bassett on evaluating strategies to improve health care service delivery in South Africa, including the implementation of the Central Chronic Medication Dispensing and Distribution program and HIV prevention services at hair salons. She also works with Dr. Bassett on a registry tracking characteristics and outcomes of hospitalized patients with COVID-19 at MGH. With Dr. McCluskey, Ashley is evaluating the impact of drug resistance and adherence on the effectiveness of Dolutegravir-based ART regimens in Uganda and South Africa.
Ashley graduated from the University of Wisconsin-Madison in 2020 with a BS in Molecular Biology and Economics.
Anisha joined MPEC in June 2020. She currently works with Dr. Mark Siedner on his projects in Uganda and South Africa focused on improving health and quality of life for people living with HIV. She also works with Dr. Anne Neilan on the MGH COVID-19 pediatric data registry and Dr. Esther Freeman on the global COVID-19 dermatology registry, which will be used to understand the impact of the disease on pediatric and dermatological patients. Outside research, she is involved with the internal Diversity, Equity, and Inclusion initiatives at MPEC.
Anisha graduated from Smith College in 2018 with a BA in Chemistry. Prior to joining the team, she was a Fulbright Scholar where she served as an English Teaching Assistant at a vocational high school, in Semarang, Central Java Indonesia.
Ogochukwu joined MPEC in August 2019. She currently works with Dr. Dugdale on modeling clinical and cost-effectiveness outcomes of broadly neutralizing antibodies (bNAbs) for the Prevention of Mother to Child Transmission (PMTCT) in resource-limited settings.
She graduated from Howard University in 2018 with a BS in Clinical Laboratory Science and a minor in Chemistry.
Nafisa joined MPEC in September 2019, after graduating from Harvard University with a BA in Molecular and Cellular Biology and a minor in Global Health and Health Policy. She spent her first year at MPEC as a Harvard Pforzheimer Postgraduate Public Service Fellow, based in Durban, South Africa.
Nafisa is working with Drs. Bassett and Jarolimova on the development and assessment of community-based HIV, STI, and reproductive care delivery in South Africa. Her projects include qualitative and quantitative assessment of a decentralized ART delivery program in South Africa, assessment of access to ART and other competing needs for people living with HIV in South Africa during the COVID-19 pandemic, and a pilot study assessing feasibility and uptake of providing preventive sexual and reproductive health services in hair salons throughout Durban, South Africa. Beyond research, Nafisa also works on MPEC’s Diversity, Equity, and Inclusion efforts.
Nattanicha Wattananimitgul graduated in 2017 with a BA in Mathematics from Pomona College and joined MPEC in August 2020.
She is currently working with Dr. Neilan on a cost-effectiveness analysis of long-acting injectable HIV pre-exposure prophylaxis to understand the clinical impacts and costs of various prophylaxis treatments. She is also working with Dr. Emily Hyle on modeling and assessing dementia among people with HIV. In addition, she helps organize bimonthly CEPAC meetings to present and discuss various MPEC modeling projects.
Former Faculty and Fellows
Aima Ahonkhai, MD, MPH
While part of MPEC, Dr. Ahonkhai was an Instructor in Medicine at Harvard Medical School and an infectious disease physician at the Massachusetts General Hospital. Her primary research interests are in improving the quality of HIV care in resource-limited settings.
Dr. Ahonkhai left MGH in 2016 and is now an Assistant Professor of Medicine in the Division of Infectious Diseases at Vanderbilt University Medical Center.
Jason Andrews, MD, MS
During his time at MPEC, Dr. Andrews conducted research exploring strategies for diagnosis and treatment of infectious diseases in resource-limited settings. His NIH-funded K01 award focused on developing models for tuberculosis transmission that incorporate the social contact structure in sub-Saharan African townships to elucidate the potential impact of interventions to control drug-resistant tuberculosis.
Dr. Andrews left MGH in 2013 and is now an Associate Professor in the Division of Infectious Diseases and Geographic Medicine at Stanford University and a practicing infectious diseases physician.
Kelli O’Laughlin, MD, MPH
Dr. O’Laughlin was a faculty member of MPEC, an attending emergency medicine physician at Brigham and Women’s Hospital, and a faculty member at the Harvard Humanitarian Initiative. She conducts operational research in low-resource settings to expand access to HIV testing and related care for refugees living in Uganda.
In 2019, Dr. O’Laughlin transitioned to her new role as an Assistant Professor in the Department of Emergency Medicine and in the Department of Global Health at the University of Washington.
Rochelle Walensky, MD, MPH
Dr. Walensky was the former Co-Director of MPEC, and the Chief of Infectious Diseases at Massachusetts General Hospital, Professor of Medicine at Harvard Medical School.
While at MPEC, her research interests included the promotion of routine HIV counseling, testing, and referral as well as the economic evaluation of HIV prevention, diagnosis, and treatment policies both in the US and internationally. She is a member of the American Society for Clinical Investigation (ASCI), the American Association of Physicians (AAP), and the Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents, the HIV Medicine Association Board of Directors, and she is past Chair of the NIH Office of AIDS Research Advisory Council. She has also been an advisor to the WHO and the UNAIDS.
Dr. Walensky earned an MD from the Johns Hopkins School of Medicine and an MPH from the Harvard T.H. Chan School of Public Health. In January 2021, Dr. Walenksy became the 19th Director of the Centers for Disease Control and Prevention.